Hisense Bio
Seongnam
About Hisense Bio
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $28.3M
- Last round: Series Unknown (Jul 2023)
- Website: hysensbio.com
- Phone: +82 02 883-2155
Industries & Categories
Biotechnology, Dental, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hisense-bio-54730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.